Background
Doctor Avorn was born February 13, 1948 in New York City and grew up in Rockaway, Queens.
Doctor Avorn was born February 13, 1948 in New York City and grew up in Rockaway, Queens.
Doctor Avorn graduated from Harvard Medical School with an Doctor of Medicine
Born February 13, 1948) is a Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital. He invented the practice of "academic detailing" in which pharmacists, nurses, and physicians educate doctors about cost-effective prescribing practices using the same tactics that drug companies employ to market their products. He received a Bachelor of Arts from Columbia University in 1969 and Doctor of Medicine from Harvard Medical School in 1974.
While attending Columbia University during the tumultuous opposition to the Vietnam War and American civil rights movement, he distinguished himself as a leading campus activist against the Vietnam War with his investigative journalism for the Columbia Daily Spectator.
In the summer of 1969, he wrote Up Against the Ivy Wall with fellow Spectator journalists about the campus uprisings at Columbia. in 1974. He was a resident at the Cambridge Hospital in Cambridge, Massachusetts and then at the Beth Israel Hospital (now the Beth Israel Deaconess Medical Center in Boston, Massachusetts).
He became an Associate Professor at Harvard Medical School in 1985 and a full Professor in 2005. In 1983, he published his first paper on academic detailing.
The practice has now been taken up by several hospitals and governments, such as Pennsylvania, Washington, District of Columbia, Kentucky, Australia, Israel, and Nova Scotia.
His work on academic detailing was featured in the Wall Street Journal and on The Daily Show. In 1996 he published Reduction of bacteriuria and pyuria after ingestion of cranberry juice in the Journal of the American Medical Association which identified cranberry juice as an effective means of controlling urinary tract infections in elderly women. Doctor Avorn is also past president of the International Society for Pharmacoepidemiology.
In 2004, he founded the Alosa Foundation, a nonprofit organization that develops and implements academic detailing programs to improve prescribing.
Doctor Avorn"s paper on coxibs was one of the first medical research papers to demonstrate that Vioxx increased some patients" risk of heart attack and stroke. In 2006 he testified as a plaintiff’s expert witness in the Vioxx litigation, but he donates all profit from his involvement to the Alosa Foundation.
They have two grown sons: Andrew Avorn (Columbia University Class of 2008, New York University Law Class of 2012), and Nathaniel Avorn (Connecticut College Class of 2003). In his leisure time, Doctor Avorn enjoys napping, reading, and traveling
Doctor Avorn is the author of the 2004 book "" About the book, Senator Edward M. Kennedy (Doctorate-Master of Arts) said, “” is a must read for anyone interested in the use, abuse, and economics of prescription drugs.
The issues it addresses are central to the ongoing debate about how to reduce the cost and improve the quality of health care in America."
-A new approach to reducing suboptimal drug use
- Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: High-risk subgroups and time course of risk
- Reduction of bacteriuria and pyuria after ingestion of cranberry juice
-Nonsteroidal anti-inflammatory drug use and acute myocardial infarction.
